Introduction
============

The obligatory intracellular bacteria, *Chlamydia psittaci* and *Chlamydia pecorum*, are globally widespread veterinary pathogens that cause disease in an astonishing range of hosts. *C. psittaci*, the causative agent of psittacosis or wasting bird disease, is regarded as a major economically relevant poultry and pet bird pathogen ([@ref-21]; [@ref-39]). Globally, *C. psittaci* infections are also sporadically reported in other animal species such as pigs, cattle, sheep and horses, resulting in asymptomatic shedding, acute respiratory disease and, in the case of horses, reproductive loss ([@ref-36]; [@ref-21]; [@ref-16]). Importantly, this pathogen continues to pose risks to public health through zoonotic transmission events that may lead to severe pneumonia ([@ref-10]; [@ref-22]; [@ref-2]). This zoonotic risk is typically associated with direct contact with *C. psittaci* infected birds, although indirect contact through exposure to environmental contamination has been suggested ([@ref-4]; [@ref-2]).

*C. pecorum* is perhaps best known as the major pathogen of the iconic Australian native species, the koala. These infections are most commonly asymptomatic but can also result in serious inflammatory ocular and/or urogenital disease, affecting almost all Australia's mainland koala populations ([@ref-35]; [@ref-12]). *C. pecorum* is also an important livestock pathogen causing a range of debilitating diseases such as sporadic bovine encephalomyelitis, polyarthritis, pneumonia and conjunctivitis, with faecal shedding as a constant feature of these infections ([@ref-23]; [@ref-36]; [@ref-43]). In livestock, chlamydial pathogens such as *C. pecorum* and *C. psittaci* may be found as co-infections, raising the possibility of a synergistic pathogenic effect ([@ref-23]; [@ref-36]; [@ref-21]). The reports of chlamydial infections in novel hosts and their recognised pathogenic potential ([@ref-17]; [@ref-5]; [@ref-40]), further highlight the need for faster detection and molecular discrimination of infecting strains.

Whilst significant progress has been made in understanding the molecular epidemiology of *C. psittaci* and *C. pecorum* infections ([@ref-15]; [@ref-2]), the diagnosis and detection of these pathogens is still difficult, laborious and costly, challenging efforts to manage and treat infected hosts. A variety of traditional (cell culture, antigen detection, and serology) and molecular (conventional and real-time quantitative PCR (qPCR)) diagnostic options are used to detect chlamydial infections and diagnose chlamydiosis ([@ref-37]). For both *C. psittaci* and *C. pecorum*, nucleic acid amplification tests (NAATs) are presently considered the diagnostic "gold standard" due to their specificity and sensitivity, however the use of these assays is mainly restricted to research and/or diagnostic laboratories. In the absence of standardised gene target(s) for these organisms, numerous single or nested species-specific qPCR assays have been proposed and/or are used for *C. psittaci* ([@ref-24]; [@ref-11]; [@ref-30]; [@ref-3]) and *C. pecorum* ([@ref-28]; [@ref-14]; [@ref-45]; [@ref-44]) diagnosis.

The development and use of low-cost molecular diagnostic tools performed at the point-of-care (POC) which fulfil the World Health Organization "ASSURED" criteria of affordable, sensitive, specific, user-friendly, rapid, equipment-free, and deliverable to those in need to be tested, are on the exponential rise ([@ref-25]). While POC testing is not necessarily required when considering most chlamydial infections of veterinary concern, the ability to provide a rapid detection of infections becomes of increasing significance when veterinarians and other animal workers may be at risk of being exposed to *C. psittaci* infections in field or farm settings. POC testing is also particularly relevant for *Chlamydia* screening in wild animals where laboratory testing is not accessible either due to logistics associated with field sampling or that services are not routinely available for testing of samples from wildlife. The latter problem is particularly acute for diagnosing infections in koalas, with the recent decision to stop the production of a commercially viable solid-phase ELISA leaving wildlife hospitals unable to diagnose and successfully treat asymptomatic *C. pecorum* infections ([@ref-13]).

While there are many options for molecular POC diagnostics, Loop Mediated Isothermal Amplification (LAMP) assays developed for use in pathogen diagnostics are popular as they offer significant advantages over PCR and/or serology testing ([@ref-25]). Rapid, simple, highly specific, easy to interpret, and carried out at a constant temperature, LAMP assays can provide a diagnosis in 30 min, in either laboratory or field setting ([@ref-27]; [@ref-32]). Rapid isothermal LAMP assays that could be performed at the POC targeting human *C. pneumoniae* ([@ref-19]) and *C. trachomatis* ([@ref-18]; [@ref-8]) infections have been proposed for use in chlamydial diagnostics. Development of a *C. pecorum* LAMP, in particular, would meet immediate demand for koala *C. pecorum* infections diagnostics, providing an alternative solution for the current laboratory diagnostics. A recent outbreak of psittacosis in veterinary staff and students in contact with a *C. psittaci*-infected and sick neonatal foal ([@ref-7]; [@ref-16]), further demonstrates the need for POC assays such as LAMP to rapidly diagnose *C. psittaci*. In the present study, we describe the development and evaluation of rapid and robust *C. psittaci*-specific and *C. pecorum*-specific LAMP assays for detection of these organisms in either laboratory or POC settings.

Materials and Methods
=====================

Bacterial cultures and clinical samples used in this study
----------------------------------------------------------

*C. psittaci* LAMP assay was evaluated using: (1) 12 DNA samples extracted from previously characterised *C. psittaci* isolates (10 human, two parrot and one equine) ([Table S1](#supp-3){ref-type="supplementary-material"}); (2) DNA extracted from 21 placental, foetal, nasal, lung and rectal swabs, and 1 each placental and foetal tissue sample taken from 20 equine hosts; and (3) three pigeon liver DNA extracts ([Table S2](#supp-4){ref-type="supplementary-material"}). All samples were collected and submitted as part of routine diagnostic testing by field or district veterinarians to the State Veterinary Diagnostic Laboratory (SVDL), Elizabeth Macarthur Agricultural Institute (EMAI), Menangle, NSW, Australia, and as such do not require special animal ethics approval. DNA extracts from these samples were kindly provided by Dr. Cheryl Jenkins, and Dr. James Branley. The use of these swabs was considered by the University of The Sunshine Coast (USC) Animal Ethics Committee and the need for further ethics consideration was waived under exemption AN/E/17/19.

*C. pecorum* LAMP was evaluated using a: (1) 18 DNA samples extracted from previously characterised koala (*n* = 7), sheep (*n* = 4), cattle (*n* = 4) and pig *C. pecorum* (*n* = 3) cultures ([Table S1](#supp-3){ref-type="supplementary-material"}); (2) 16 sheep and 13 cattle ocular, rectal, and tissue swab DNA samples; and (3) 34 ocular and urogenital (UGT) koala swab DNA samples ([Table S3](#supp-5){ref-type="supplementary-material"}), all available in our collection. The use of these swabs, also collected by qualified veterinarians as a part of routine diagnostic testing, was considered and approved for exemption by the University of The Sunshine Coast (USC) Animal Ethics Committee (AN/E/14/01 and AN/E/14/31).

We also evaluated the specificity of the assays against DNA samples extracted from previously characterised (i) chlamydial isolates (koala C*. pneumoniae* LPColN, *C. abortus* S26/3, *C. suis* S45, *C. trachomatis* serovar D, *C. murridarum* Nigg, *C. caviae* GPIC) and uncultured *Chlamydiales* (*Fritschea* spp.); (ii) Gram negative *Escherichia coli* and *Prevotella bivia*; Gram positive *Fusobacterium nucleatum*, *Staphylococcus epidermidis*, *S. aureus*, *Streptococcus* spp., and *Enterococcus faecalis*; and (iii) commercially available human gDNA (Promega, Alexandria, NSW 2015), all available in our laboratory ([Table S1](#supp-3){ref-type="supplementary-material"}).

In order to evaluate rapid swab processing, 18 ocular, cloacal and UGT (14 dry and four RNA-Later) clinical swabs taken from 14 koalas with presumptive chlamydiosis were used for testing without DNA extraction. Briefly, RNA-Later and dry swabs with added 500 µL TE buffer were vortexed vigorously for 5 min. 300 µL aliquots were then heated to 98 °C for 15 min to lyse DNA, following LAMP testing. The use of these swabs, collected as a part of routine diagnostic testing, is also under Animal Ethics approval exemption (AN/E/14/01). An aliquot of 50 µL of the swab suspension was used for LAMP and qPCR assays, while from the remaining volume of the swab suspension was used for DNA extraction, in order to compare swab suspension and its paired extracted DNA as a template in the assays.

LAMP assays design
------------------

For the *C. psittaci*-specific LAMP gene target, we targeted a previously described conserved single-copy *C. psittaci*-specific CDS, encoding for hypothetical protein and denoted *Cpsi*t_0607 in the representative *C. psittaci* 6BC strain (Genbank accession number [NC_015470.1](http://www.ncbi.nlm.nih.gov/nuccore/NC_015470.1)) ([@ref-42]). This gene was also previously proposed as a target for molecular diagnosis of *C. psittaci* infections ([@ref-33]).

The *C. pecorum*-specific candidate LAMP gene target, encoding for a single-copy conserved hypothetical protein and denoted CpecG_0573 in the *C. pecorum* MC/Marsbar koala type strain (GenBank accession number [NZ_CM002310.1](http://www.ncbi.nlm.nih.gov/nuccore/NZ_CM002310.1)), was selected based on a comparative genomics analysis of published koala and livestock *C. pecorum* genomes ([@ref-15]). For the purposes of this study, we will refer to it as *Cpec*\_HP. Both candidate gene sequences were aligned to the corresponding allele from other publicly available *C. psittaci* or *C. pecorum* strains using Clustal X (as implemented in Geneious 9 ([@ref-20])), and analysed in blastn against the nucleotide collection nr/nt database to assess intra-species sequence identity, and inter-species specificity.

For *C. ps*\_0607 alignment, besides 6BC, we used the gene alleles from strains 84/55 ([CP003790.1](http://www.ncbi.nlm.nih.gov/nuccore/CP003790.1)), 02DC15 ([CP002806.1](http://www.ncbi.nlm.nih.gov/nuccore/CP002806.1)), 01DC11 ([CP002805.1](http://www.ncbi.nlm.nih.gov/nuccore/CP002805.1)), WC ([CP003796.1](http://www.ncbi.nlm.nih.gov/nuccore/CP003796.1)), 01DC12 ([HF545614.1](http://www.ncbi.nlm.nih.gov/nuccore/HF545614.1)), NJ1 ([CP003798.1](http://www.ncbi.nlm.nih.gov/nuccore/CP003798.1)), CR009 ([LZRX01000000](https://www.ncbi.nlm.nih.gov/nucleotide?term=LZRX01000000)), Ho Re upper ([LZRE01000000](https://www.ncbi.nlm.nih.gov/nucleotide?term=LZRE01000000)) and PoAn ([LZRG01000000](https://www.ncbi.nlm.nih.gov/nucleotide?term=LZRG01000000)). For *C. pec* \_HP alignment, besides MC/Marsbar, we used the gene alleles from E58 ([CP002608.1](http://www.ncbi.nlm.nih.gov/nuccore/CP002608.1)), P787 ([CP004035.1](http://www.ncbi.nlm.nih.gov/nuccore/CP004035.1)), W73 ([CP004034.1](http://www.ncbi.nlm.nih.gov/nuccore/CP004034.1)), IPA ([NZ_CM002311.1](https://www.ncbi.nlm.nih.gov/nucleotide?term=NZ˙CM002311.1)), NSW/Bov/SBE ([NZ_JWHE00000000.1](https://www.ncbi.nlm.nih.gov/nucleotide?term=NZ˙JWHE00000000.1)), L71 ([LFRL01000000](https://www.ncbi.nlm.nih.gov/nucleotide?term=LFRL01000000)), L17 ([LFRK01000001](https://www.ncbi.nlm.nih.gov/nucleotide?term=LFRK01000001)), L1 ([LFRH00000000](https://www.ncbi.nlm.nih.gov/nucleotide?term=LFRH00000000)), DBDeUG ([NZ_CM002308.1](https://www.ncbi.nlm.nih.gov/nucleotide?term=NZ˙CM002308.1)), SA/K2/UGT ([SRR1693792](https://www.ncbi.nlm.nih.gov/sra?term=SRR1693792)), Nar/S22/Rec ([SRR1693794](https://www.ncbi.nlm.nih.gov/sra?term=SRR1693794)) and Mer/Ovi1/Jnt ([SRR1693791](https://www.ncbi.nlm.nih.gov/sra?term=SRR1693791)).

Species-specific LAMP primers were designed using the target sequences with the open-source Primer Explorer v5 software (Eiken Chemical Co., Tokyo, Japan) and licensed LAMP Designer 1.15 software (Premier Biosoft, Palo Alto, CA, USA). For both *C. pecorum* and *C. psittaci*, Primer Explorer v5 yielded five sets of four LAMP primers including two outer (forward F3 and backward B3) primers and two inner (forward inner FIP and backward inner BIP) primers targeting different regions of the target gene, while LAMP Designer yielded single best set of six LAMP primers including two outer primers (forward F3 and backward B3), two inner primers (forward inner FIP and backward inner BIP) and two loop primers (forward loop LF and backwards loop LB). All primers (as single or paired) were tested *in silico*, including analysing primer sequences in blast for species specificity and OligoAnalyser 3.1 (available from <http://sg.idtdna.com/calc/analyzer>) for primer dimerization, hairpins and melting temperatures.

After *in silico* and in LAMP reaction testing, a set of four primers designed by PrimerExplorer v5 and targeting a 209 bp region of the *C. pec\_*HP gene (spanning from position 22 to 230) was selected for *C. pecorum* LAMP assays performed in this study. Additional loop primers (LF/LB) were also designed to accelerate amplification time and increase sensitivity. For *C. psittaci*, a set of six primers designed with LAMP Designer and targeting a 263 bp region of the *C. ps\_*0607 gene (spanning from position 286 to 548) was selected for LAMP assays performed in this study. The specificity of primer sequences was assessed *in silico* using discontiquousBLAST analyses. Amplicons generated by conventional PCR using outer F3 and B3 primers for both *C. psittaci* and *C. pecorum* were gel excised, purified using Roche High Pure purification kit, and sent to Australian Genome Research Facility (AGRF) for Sanger sequencing for sequence identity confirmation.

LAMP assay optimisation
-----------------------

Both *C. psittaci* and *C. pecorum* LAMP assays were carried out in a 25 µL reaction volume. The reaction mixture consisted of 15 µL Isothermal Master Mix ISO001 (Optigene, Horsham, UK), 5 µL six primers mix (at 0.2 µM F3 and B3, 0.8 µM FIP and BIP, and 0.4 µM LF and LB) and 5 µL template, following LAMP assay run at 65 °C in the Genie III real-time fluorometer (Optigene, Horsham, UK), as per manufacturer instructions. Following determination of the most optimal conditions (fastest amplification time, fluorescence and annealing temperature), *C. psittaci* LAMP assays were run at 65 °C for 30 min followed by annealing step of 98--80 °C at a rate of 0.05 °C/s, while *C. pecorum* LAMP assays were run using the same temperature and annealing conditions, however for 45 min. A negative control (LAMP mix only) was included in each run. Both *C. psittaci* and *C. pecorum* LAMP assays were performed on a thermal cycle heating block at 65 °C for 30 min, following detection of amplicons by electrophoresis on a 1.5% ethidium bromide agarose gel and visualisation under UV. In addition, several *C. pecorum* LAMP assays were conducted using the four primer set, two outer (F3 and B3) and two inner (FIP and BIP) primers, on a heating block at 65 °C for 45 min.

After the assay optimisation, LAMP testing was evaluated using previously tested clinical samples, previously characterised isolates and untested new samples. *C. pecorum*-presumptive samples were simultaneously tested using our in-house *C. pecorum*--specific qPCR assay ([@ref-28]), while *C. psittaci*-presumptive samples were tested using a pan-*Chlamydiales* qPCR assay with primers 16SIGF and 16SIGR targeting the 298 bp 16S rRNA fragment ([@ref-9]). Amplicon sequencing was used for the latter assay to confirm species identity. The qPCR assays were carried out in a 20 µL total volume, consisting of 10 µL SYBR™ Green PCR Master Mix (Life Technologies Australia Pty Ltd., Scoresby, Victoria, Australia), 1 µL of each 10 µM forward and reverse primer, 3 µL miliqH2O, and 5 µL DNA template. The qPCR assays were run for 35 cycles (Ct), and in each qPCR assay a positive (cultured *C. pecorum* and/or *C. psittaci* DNA) and negative (miliqH2O) controls were included. Based on the qPCR standard curve and the number of running cycles, samples amplifying at \>30 Ct (and/or equivalent detected genome copy number) were considered negative. The 23 *C. psittaci*-presumptive equine samples were also tested with a *C. psittaci*-specific qPCR assay targeting the 16S rRNA gene/16S-23S rRNA spacer gene ([@ref-24]) at the State Veterinary Diagnostic Laboratory (SVDL), Elizabeth Macarthur Agricultural Institute (EMAI), Menangle, NSW, Australia. Samples amplifying at \>39 Ct were considered negative. LAMP testing was performed in a blind fashion, by two different operators, unaware of qPCR results.

Statistical analyses
--------------------

For each assay, we compared the performance of two tests evaluated in the same population by calculating Kappa and overall agreement, as well as estimated sensitivity and specificity (with specified Clopper--Pearson (exact) confidence limits) of LAMP compared to the known reference (gold standard) qPCR test using EpiTools online ([@ref-38]). It is suggested the Kappa value be interpreted as follows: values ≤0 as indicating no agreement and 0.01--0.20 as none to slight, 0.21--0.40 as fair, 0.41--0.60 as moderate, 0.61--0.80 as substantial, and 0.81--1.00 as almost perfect agreement.

Results and Discussion
======================

With the emergence of new spill-over threats posed by *C. psittaci* ([@ref-22]; [@ref-16]), there is an increasing need for rapid diagnostic tools for this pathogen, particularly for those that may have practical application in the field or clinical setting. There are specific needs for *C. pecorum* POC tests as well in both the veterinary care and treatment of infected domesticated and native animals, particularly in settings where veterinary diagnostic testing is logistically challenging. In the present study, to the best of our knowledge, we describe the first development of novel, rapid and robust *C. psittaci*-specific and *C. pecorum*-specific LAMP assays that are able to detect these bacteria in clinical samples in either the laboratory or POC settings.

*C. psittaci* and *C. pecorum* LAMP development
-----------------------------------------------

A *C. psittaci*-specifi*c* gene (*C.ps*\_0607) was previously characterised as a conserved gene sequence present only in *C. psittaci* genomes, and absent from all other related chlamydial species ([@ref-42]). BLAST analyses and alignment of the *C.ps*\_0607 gene sequences, including those from recently described human, bird and equine Australian isolates, confirmed species specificity and sequence conservation. Between 0 and 13 single nucleotide polymorphisms (SNPs) were observed amongst strains (100--95.1% sequence identity) based on a 263 bp alignment of *C.ps*\_0607 gene sequences, including that from the most distant *C. psittaci* NJ1 taxon ([Fig. S1A](#supp-1){ref-type="supplementary-material"}). Similarly, the *C. pecorum* HP gene (denoted CpecG_0573 locus in Marsbar strain) was determined as a highly conserved species-specific sequence following BLAST analysis against publicly available sequences. Using an alignment of HP gene sequences from 14 publicly available *C. pecorum* genomes, there were only two SNPs in the 209 bp region to be targeted by LAMP ([Fig. S1B](#supp-1){ref-type="supplementary-material"}).

Although multiple LAMP primer sets were predicted, LAMP primer sets denoted in [Fig. 1](#fig-1){ref-type="fig"} were chosen for further assay development. For *C. psittaci* assays, a set designed using LAMP Explorer was utilised while, for *C. pecorum*, we used a set designed with PrimerExplorer ([Table 1](#table-1){ref-type="table"}). After initial testing, some of the predicted primer sets were discarded due to (i) potential cross-amplification associated with a lack of specificity of the target primer; (ii) not achieving an amplification signal in the fluorometer; and (iii) amplifying non-specific targets, including positive amplification in negative controls (data not shown). While we achieved initial amplification of a *C. psittaci* single copy dilution in a 30 min assay using the designed LAMP primer set, initial reaction times for a *C. pecorum* single copy amplification averaged 50 min. In order to accelerate amplification times for *C. pecorum*, we additionally designed a pair of Loop primers for the *C. pecorum* set which decreased the amplification of a single copy to 30 min.

![LAMP primer sequences and positions in the target gene regions.\
(A) *C. psittaci* LAMP primer set; and (B) *C. pecorum* LAMP primer set. Outer F3 and B3 primers are indicated in green, inner FIP and BIP in blue, and loop LF and BL in pink colour.](peerj-05-3799-g001){#fig-1}
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###### LAMP primers set used in this study.

![](peerj-05-3799-g002)

  Name                            Sequence 5′--3′                                   Position   Length
  ------------------------------- ------------------------------------------------- ---------- --------
  ***C. psittaci*LAMP primers**                                                                
  F3                              AGAACCGGATTAGGAGTCTT                              286        20
  B3                              GCTGCTAAAGCGAGTATTGA                              548        20
  FIP(F1c + F2)                   TCCGCAGTTTGTTCCATCACCCAA GGGTTATTCGACAACTACT                 43
  BIP(B1c + B2)                   ACTATGGATCGGCCACACATGGG TATGTTGCTTTGAATGGG                   41
  LoopF                           TTCAGGTAATCACGCACTTGA                             350        21
  LoopB                           TTCCCCACACTATTAAACAGCA                            431        22
  F2                              CAAGGGTTATTCGACAACTACT                            307        22
  F1c                             TCCGCAGTTTGTTCCATCACC                             387        21
  B2                              GGTATGTTGCTTTGAATGGG                              472        20
  B1c                             ACTATGGATCGGCCACACATG                             410        21
  ***C. pecorum*LAMP primers**                                                                 
  F3                              ATCGGGACCTTCTCATCG                                22         18
  B3                              GCTGTTGTAAGGAAGACTCC                              230        20
  FIP(F1c + F2)                   GACTAACAGTATAAGCAGTGCTG TTAGTCTGCTGTCCAACTACA                44
  BIP(B1c + B2)                   TTATCTCTCGTTGCAATGATAGGAG CCAACAGGATCAAACCAACTT              46
  LoopF                           CTGAATTCGTTGAC                                    93         14
  LoopB                           TACTGTCTTCACC                                     165        12
  F2                              AGTCTGCTGTCCAACTACA                               47         19
  F1c                             GACTAACAGTATAAGCAGTGCTGTT                         129        25
  B2                              CAACAGGATCAAACCAACTT                              210        20
  B1c                             TTATCTCTCGTTGCAATGATAGGAGC                        130        26

Species-specificity for *C. psittaci* and *C. pecorum* LAMP targets was tested in the developed LAMP assays using DNA extracts from 12 *C. psittaci* and 18 *C. pecorum* cultured isolates, DNA extracts from other chlamydial species and a range of DNA extracts from other bacteria. Positive amplification as assessed by the presence of an observable amplification curve characterised by a specific melt was observed only for the target species in their respective assays ([Table S1](#supp-3){ref-type="supplementary-material"}). No amplification curves were observed for any of the non-targeted chlamydial species or other bacteria included in our specificity assays ([Table S1](#supp-3){ref-type="supplementary-material"}). The *C. pecorum* and *C. psittaci* LAMP assays did not amplify either the related chlamydial species or other bacteria included in our specificity assays. In this study, in contrast, a previously described "*C. pecorum*-specific" qPCR assay ([@ref-28]; [@ref-45]) showed positive amplification and melt for *C. psittaci* and *C. pneumoniae* DNA samples.

The choice to use the *C. ps*\_0607 gene as a LAMP target was straight forward since it had been suggested for such a purpose in previous studies ([@ref-42]; [@ref-33]), For *C. pecorum*, however, we utilised our ongoing comparative genomics to select *C. pecorum*-specific and conserved *C.pec*\_HP gene described in this study for the first time. *In silico* analyses and assay development confirmed species-specificity of this gene and its suitability for use in diagnostic assays. Previously published *C. pecorum* diagnostic assays targeted highly polymorphic genes such as *omp*A ([@ref-14]; [@ref-46]), which may require the use of probes due to sequence variation, prolonging the detection time and increasing diagnostic costs. Our routinely used in house *C. pecorum*-specific assay which targets a 204 bp 16S rRNA fragment ([@ref-28]; [@ref-45]) was simpler to use, however we have shown that this assay may cross-react with other related chlamydial species due to a lack of sufficient sequence variation in the region of the 16S rRNA gene targeted ([@ref-1]). For koala diagnostics where *C. pecorum* is the most abundant and prevalent chlamydial organism ([@ref-35]), this cross-reactivity may not be of a big concern. For the veterinary diagnosis of infections in livestock where co-infections with several chlamydial species are common ([@ref-23]; [@ref-36]), this assay may be less suitable. Using the *C. pecorum*-specific HP gene as a target in different diagnostic assays would hence seem promising.

Performance of the *C. psittaci* and *C. pecorum* LAMP assays
-------------------------------------------------------------

The sensitivity of the LAMP assays was evaluated using 5 µL cultured *C. psittaci* and *C. pecorum* gDNA in 10-fold serial dilutions as a template in assays performed in triplicate in separate runs. The limits of detection of the LAMP assays were conservatively 10 copies for *C. psittaci*, with 3/3 (100%) positive amplification for 10 copy dilutions for *C. psittaci*, and one copy for *C. pecorum*, with 3/3 (100%) positive amplifications for a single copy dilution of *C. pecorum* DNA ([Tables 2](#table-2){ref-type="table"} and [3](#table-3){ref-type="table"}). In the final and optimised LAMP assays, the mean amplification time detecting the lower limit (a single copy) for *C. psittaci* was 14.23 min with an average 84.45 °C melt ([Table 2](#table-2){ref-type="table"}) while, for *C. pecorum,* it was 24 min with an average 83.42 °C melt ([Table 3](#table-3){ref-type="table"}). Comparing the two newly developed assays, *C. psittaci* LAMP had the faster run time than that of *C. pecorum* LAMP. This difference in assays kinetics could be attributed to the improved *C. psittaci* LAMP primers design, as they were predicted by the LAMP Designer software ([@ref-31]). As we additionally designed Loop primers for *C. pecorum*, we can anticipate an improvement in the *C. pecorum* assay kinetics by re-designing the loop primers (e.g., extending the sequence to 20--22 bp), as well as testing LAMP mixes in different ratios and with improved polymerases.
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###### *C. psittaci* LAMP assay[^a^](#table-2fn1){ref-type="fn"} sensitivity.

![](peerj-05-3799-g003)

  Dilution[^d^](#table-2fn4){ref-type="fn"}   Time to amplify (min)                 Melt (°C)                                Time (Mean + SD)   Melt (Mean + SD)
  ------------------------------------------- ------------------------------------- ---------------------------------------- ------------------ ------------------
  10^6^                                       5.15                                  84.43                                    5.10, 0.09         84.49, 0.08
  10^6^                                       5.00                                  84.46                                                       
  10^6^                                       5.15                                  84.58                                                       
  10^5^                                       6.30                                  84.34                                    6.30, 0.15         84.37, 0.06
  10^5^                                       6.45                                  84.33                                                       
  10^5^                                       6.15                                  84.43                                                       
  10^4^                                       7.15                                  84.59                                    7.25, 0.09         84.56, 0.04
  10^4^                                       7.30                                  84.58                                                       
  10^4^                                       7.30                                  84.51                                                       
  10^3^                                       8.45                                  84.46                                    8.25, 0.173        84.44, 0.01
  10^3^                                       8.15                                  84.43                                                       
  10^3^                                       8.15                                  84.44                                                       
  100                                         9.15                                  84.48                                    9.30, 0.15         84.46, 0.06
  100                                         9.30                                  84.39                                                       
  100                                         9.45                                  84.51                                                       
  10                                          12.00                                 84.41                                    11.33, 0.58        84.38, 0.03
  10                                          11.00                                 84.35                                                       
  10                                          11.00                                 84.39                                                       
  1                                           16.00                                 84.44                                    14.23, 2.51        84.34, 0.14
  1                                           0.00                                  0                                                           
  1                                           12.45                                 84.24                                                       
  0.1                                         25.25                                 84.20                                                       
  0.1                                         --[^b^](#table-2fn2){ref-type="fn"}   --                                       --                 84.20
  0.1                                         --                                    84.20[^c^](#table-2fn3){ref-type="fn"}                      

**Notes.**

The assay was performed in Genie III Real-time fluorometer, with the amplification times and annealing temperatures recorded at the end of each run. The samples were tested in three different runs.

No amplification detected.

No amplification, but melt and annealing curve recorded.

Template was serially diluted *C. psittaci* CR009 gDNA which genome copy number was determined by qPCR.

10.7717/peerj.3799/table-3

###### *C. pecorum* LAMP assay[^e^](#table-3fn5){ref-type="fn"} sensitivity.

![](peerj-05-3799-g004)

  Dilution[^f^](#table-3fn6){ref-type="fn"}   Time to amplify (min)                 Melt (°C)   Time (Mean + SD)   Melt (Mean + SD)
  ------------------------------------------- ------------------------------------- ----------- ------------------ ------------------
  10^7^k[^a^](#table-3fn1){ref-type="fn"}     10.00                                 83.23       10.23, 0.32        83.30, 0.1
  10^7^k                                      10.45                                 83.37                          
  10^6^k                                      13.15                                 83.57       12.92, 0.40        83.51, 0.16
  10^6^s[^b^](#table-3fn2){ref-type="fn"}     13.15                                 83.33                          
  10^6^c[^c^](#table-3fn3){ref-type="fn"}     12.45                                 83.62                          
  10^5^k                                      14.00                                 83.52       14.10, 0.17        83.48, 0.11
  10^5^s                                      14.00                                 83.35                          
  10^5^c                                      14.30                                 83.57                          
  10^4^k                                      15.45                                 83.56       16.30, 0.78        83.44, 0.11
  10^4^s                                      16.45                                 83.33                          
  10^4^c                                      17.00                                 83.42                          
  10^3^k                                      19.00                                 83.50       18.87, 1.35        83.45, 0.06
  10^3^s                                      17.45                                 83.39                          
  10^3^c                                      20.15                                 83.47                          
  100k                                        20.15                                 83.47       20.35, 2.00        83.33, 0.21
  100s                                        18.45                                 83.09                          
  100c                                        22.45                                 83.42                          
  10k                                         22.30                                 83.52       22.43, 1.50        83.42, 0.1
  10s                                         21.00                                 83.42                          
  10c                                         24.00                                 83.33                          
  1k                                          23.15                                 83.52       23.92, 2.11        83.41, 0.12
  1s                                          22.30                                 83.42                          
  1c                                          26.30                                 83.28                          
  0.1k                                        36.00                                 83.41       34.65, 1.91        83.39, 0.06
  0.1s                                        --[^d^](#table-3fn4){ref-type="fn"}   83.43                          
  0.1c                                        33.30                                 83.33                          

**Notes.**

Koala Marsbar isolate.

Sheep IPA isolate.

Cattle E58 isolate.

No amplification, but melt and annealing curve recorded.

The assay was performed in Genie III Real-time fluorometer, with the amplification times and annealing temperatures recorded at the end of each run. The samples were tested in different runs.

Template was serially diluted *C. pecorum* gDNA which genome copy number was determined by qPCR.

In order to test the reproducibility of our LAMP assays, we tested a subset of *C. pecorum* and *C. psittaci* PCR positive samples ([Table 4](#table-4){ref-type="table"}). All samples were run in a "blind fashion", in triplicate and in separate runs by two different operators. For both assays, the amplification times and melts of each sample between the runs were very similar, with 0 to 1.5 min (SDs ranging from 0--0.98) difference in amplification times for each sample, and 0.03 to 0.83 °C (SDs ranging from 0.02--0.26) difference in melt for each sample. Congruence between the runs performed by different operators indicates that both LAMP assays described in this study are highly reproducible, and can detect the target organism in less than 30 min even when in low infectious loads of \<10 copies.
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###### Reproducibility of the LAMP testing using clinical and cultured samples.
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  Samples                             Run[^a^](#table-4fn1){ref-type="fn"}   Time to amplify (min)   Melt (°C)   Time (Mean + SD)   Melt (Mean + SD)
  ----------------------------------- -------------------------------------- ----------------------- ----------- ------------------ ------------------
  ***C. pecorum*positive samples**                                                                                                  
  Koala rectal swab                   1                                      20.15                   83.44       20.53, 0.54        83.32, 0.16
  2                                   20.30                                  83.37                                                  
  3                                   21.15                                  83.14                                                  
  Marsbar DNA                         1                                      13.50                   83.50       13.27, 0.20        83.55, 0.06
  2                                   13.15                                  83.52                                                  
  3                                   13.15                                  83.62                                                  
  Koala A2 DNA                        1                                      12.00                   83.35       11.43, 0.51        83.41, 0.05
  2                                   11.00                                  83.45                                                  
  3                                   11.30                                  83.43                                                  
  RI koala UGT swab                   1                                      17.00                   83.34       17.72, 0.62        83.21, 0.12
  2                                   18.00                                  83.21                                                  
  3                                   18.15                                  83.09                                                  
  L14 DNA                             1                                      13.15                   83.53       13.15, 0           83.50, 0.02
  2                                   13.15                                  83.50                                                  
  3                                   13.15                                  83.48                                                  
  HsLuRz DNA                          1                                      13.45                   83.49       13.63, 0.32        83.40, 0.08
  2                                   13.45                                  83.36                                                  
  3                                   14.00                                  83.34                                                  
  K20 cloaca swab                     1                                      22.00                   82.83       22.2, 0.23         83.01, 0.19
  2                                   22.15                                  83.00                                                  
  3                                   22.45                                  83.20                                                  
  ***C. psittaci*positive samples**                                                                                                 
  Cr009 DNA                           1                                      6.45                    84.30       6.40, 0.09         84.33, 0.03
  2                                   6.45                                   84.36                                                  
  3                                   6.30                                   84.34                                                  
  HoRE DNA                            1                                      5.00                    84.46       5.10, 0.08         84.45, 0.14
  2                                   5.15                                   84.58                                                  
  3                                   5.15                                   84.30                                                  
  B2 DNA                              1                                      10.30                   84.08       10.10, 0.17        84.17, 0.08
  2                                   10.00                                  84.20                                                  
  3                                   10.00                                  84.24                                                  
  Horse placental swab                1                                      11.15                   82.90       10.58, 0.49        83.19, 0.26
  2                                   10.30                                  83.42                                                  
  3                                   10.30                                  83.24                                                  
  Horse_pl DNA                        1                                      10.30                   84.53       10.87, 0.98        84.41, 0.18
  2                                   12.00                                  84.21                                                  
  3                                   10.30                                  84.50                                                  

**Notes.**

The assay was performed in Genie III Real-time fluorometer, with the amplification times and annealing temperatures recorded at the end of each run. The samples were tested in three different runs by two different operators.

Pathogen detection in clinical samples using newly developed LAMP
-----------------------------------------------------------------

For *C. psittaci*, a total of 26 DNA extracts from clinical samples were tested with both *C. psittaci* LAMP and qPCR assays ([Table S2](#supp-4){ref-type="supplementary-material"}). For these analyses, samples with \>20 min amplification time were considered negative for LAMP, while for qPCR, samples with \<20 genome copy/reaction and/or \>30 Ct (quantification cycle) were considered negative, based on the qPCR standard curve and the number of running cycles used for this testing. As observed in [Table S2](#supp-4){ref-type="supplementary-material"} and based on above cut-off values, 24/26 (92.3%) samples were congruent between the two tests, with 11 samples positive and 13 samples negative by both ([Table 5](#table-5){ref-type="table"}). For 2/26 (7.7%) where there was disagreement, one sample was LAMP positive but qPCR negative, and another was qPCR positive but *C. psittaci* LAMP negative. Based on these results, the Kappa value was calculated at 0.85 (95% CI \[0.64--1.05\]) indicating an almost perfect agreement between the tests. The overall sensitivity of the *C. psittaci* LAMP was 91.7% (Clopper--Pearson 95% CI \[0.62--0.99\]) and with 92.9% (Clopper--Pearson 95% CI \[0.66--0.99\]) specificity, compared to the qPCR used in this study. In addition, a subset of 23 samples was also tested independently by a third party. Using a cut off of \>Ct 39 as negative, 19/23 (82.60 %) of these test results were in congruence with our *C. psittaci* LAMP results ([Table S2](#supp-4){ref-type="supplementary-material"}).

10.7717/peerj.3799/table-5

###### Comparison of the *C. psittaci* LAMP and qPCR methods for the organism detection in clinical samples.
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  Test         qPCR +ve   qPCR −ve   qPCR Total
  ------------ ---------- ---------- ------------
  LAMP +ve     11         1          12
  LAMP −ve     1          13         14
  LAMP Total   12         14         26

For *C. pecorum*, we tested a total of 63 DNA extracts from clinical samples from several animal hosts by both LAMP and qPCR ([Table S3](#supp-5){ref-type="supplementary-material"}). For these analyses, samples with \>30 min amplification time were considered negative for LAMP, while for qPCR, samples with \<35 genome copy /reaction and/or \>30 Ct were considered negative based on the standard curve and number of run cycles used for this testing. For the 63 clinical samples, the overall congruence was 84.1% with a Kappa value of 0.68 (95% CI \[0.50--0.86\]), indicating substantial agreement between the tests. Congruent results between tests were obtained for 53 samples, while there were 10 discrepant samples using the above cut off for *C. pecorum* ([Table 6](#table-6){ref-type="table"}). The overall sensitivity of *C. pecorum* LAMP was 90.6 % (Clopper--Pearson 95% CI \[0.75--0.98\]), while specificity was 77.4 % (Clopper--Pearson 95% CI \[0.59--0.90\]) in comparison to the qPCR assay. A subset of 36 *C. pecorum* samples was also tested in a thermal cycler using the newly developed LAMP and results were determined as an end point detection. For this experiment, 34/36 (94.4%) samples were congruent between LAMP performed in fluorometer and in a thermal cycler ([Table S3](#supp-5){ref-type="supplementary-material"}), demonstrating the robustness of the *C. pecorum* LAMP ([Fig. S2](#supp-2){ref-type="supplementary-material"}).
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###### Comparison of the *C. pecorum* LAMP and qPCR methods for the organism detection in clinical samples.
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  Test         16s +ve   16s −ve   16s Total
  ------------ --------- --------- -----------
  LAMP +ve     29        7         36
  LAMP −ve     3         24        27
  LAMP Total   32        31        63
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###### Comparison of *C. pecorum* LAMP and qPCR for organism detection using rapidly processed swab samples and their DNA extracts.
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  Sample                                       LAMP[^a^](#table-7fn1){ref-type="fn"} result for swab suspension   qPCR[^b^](#table-7fn2){ref-type="fn"} result for swab suspension   LAMP result for DNA extract   qPCR result for DNA extract   LAMP result for "spiked" swab suspension   LAMP result for "spiked" DNA extract   qPCR result for "spiked" swab suspension   qPCR result for "spiked" DNA extract
  -------------------------------------------- ------------------------------------------------------------------ ------------------------------------------------------------------ ----------------------------- ----------------------------- ------------------------------------------ -------------------------------------- ------------------------------------------ --------------------------------------
  K1 ocular[^c^](#table-7fn3){ref-type="fn"}   NEG                                                                NEG                                                                0.00/83.49                    NEG                           NEG                                        --                                     NEG                                        --
  K6 ocular[^c^](#table-7fn3){ref-type="fn"}   NEG                                                                NEG                                                                21.00/83.23                   3 × 10^3^ (Ct 20)             NEG                                        --                                     NEG                                        --
  K9 ocular[^c^](#table-7fn3){ref-type="fn"}   NEG                                                                NEG                                                                25.45/83.39                   287 (Ct 24)                   NEG                                        --                                     NEG                                        --
  K2 ocular[^c^](#table-7fn3){ref-type="fn"}   NEG                                                                NEG                                                                NEG                           NEG                           NEG                                        --                                     NEG                                        --
  R1 eye                                       25.45/83.39                                                        222 (Ct 25)                                                        20.15/83.27                   750 (Ct 24)                   --                                         --                                     --                                         --
  R1 cloaca                                    30.00/83.34                                                        NEG                                                                NEG                           NEG                           11.15/83.47                                12.15/83.42                            5 × 10^3^ (Ct 17)                          1.5 × 10^3^ (Ct 18)
  K eye                                        27.00/83.15                                                        NEG                                                                0.00/83.35                    NEG                           --                                         --                                     --                                         --
  Koala 2 eye                                  NEG                                                                NEG                                                                NEG                           NEG                           11.00/83.51                                11.00/83.40                            1.2 × 10^3^ (Ct 19)                        1.1 × 10^4^ (Ct 15)
  Koala 2 cloaca                               27.30/83.77                                                        116 (Ct 26)                                                        21.30/83.49                   375 (Ct 25)                   --                                         --                                     --                                         --
  Will Cloaca                                  0.00/83.77                                                         NEG                                                                NEG                           NEG                           12.00/83.45                                11.00/83.34                            1.5 × 10^3^ (Ct 19)                        8 × 10^3^ (Ct 17)
  23117 Eye                                    21.30/83.20                                                        NEG                                                                23.15/83.23                   150 (Ct 25)                   --                                         --                                     --                                         --
  23117 Cloaca                                 22.00/83.29                                                        NEG                                                                24.00/83.15                   90 (Ct 27)                    --                                         --                                     --                                         --
  Flyn eye                                     NEG                                                                NEG                                                                NEG                           NEG                           12.30/83.50                                11.00/83.35                            1.9 × 10^3^ (Ct 18)                        8.3 × 10^3^ (Ct 16)
  Tyke eye                                     NEG                                                                NEG                                                                NEG                           NEG                           12.00/83.44                                10.45/83.40                            1.3 × 10^3^ (Ct 19)                        9 × 10^3^ (Ct 16)
  Bill eye                                     NEG                                                                NEG                                                                NEG                           NEG                           12.15/83.49                                10.45/83.34                            1.2 × 10^3^ (Ct 19)                        1 × 10^4^ (Ct 15)
  Ray eye                                      NEG                                                                NEG                                                                NEG                           NEG                           12.45/83.49                                11.00/83.40                            4.7 × 10^3^ (Ct 17)                        1 × 10^4^ (Ct 15)
  Ray cloaca                                   NEG                                                                NEG                                                                NEG                           NEG                           12.15/83.43                                11.00/83.30                            700 (Ct 20)                                9 × 10^3^ (Ct 16)
  Koala F Eye                                  NEG                                                                NEG                                                                NEG                           NEG                           11.45/83.45                                11.00/83.35                            1.3 × 10^3^ (Ct 19)                        1.1 × 10^4^ (Ct 15)

**Notes.**

LAMP results are expressed as time to amplify (min) and melt (°C).

qPCR results are expressed as copies/reaction and Ct value.

RNA Later swabs.

Considering that the qPCR assay used in this study to quantify and detect *C. psittaci* is chlamydial genus rather species specific ([@ref-9]), high congruence observed for *C. psittaci* assays could be attributed to testing a limited set of samples taken from hosts with presumptive *C. psittaci* chlamydiosis. Lower congruence between the *C. pecorum*-specific assays could be due to technical and experimental aspects and characteristics (such as the assay efficiency, analytical sensitivity, template preparation) ([@ref-6]) of the *C. pecorum* 16S qPCR assay used in this study. As a sidenote, we also evaluated the use of *C. psittaci* and *C. pecorum* LAMP targets (263 bp of the *C. ps*\_0607 and 209 bp *C. pec*\_HP genes, respectively) using outer F3 and B3 primers in a fluorescence-based (SybrGreen) qPCR assays, if needed to estimate infectious loads of the pathogen. In this preliminary analyses, both targets seem suitable for use in qPCR assays as well, as we were able to detect low infectious load up to 10 copies/reaction in a sample.

### Rapid swab processing

Rapid swab processing and using the swab suspension directly in LAMP assays were previously successfully evaluated for testing for respiratory syncytial virus from nasopharyngeal swabs ([@ref-26]) and rapid detection of *Streptococcus agalactiae* in vaginal swabs ([@ref-29]). A recent study also demonstrated that *C. trachomatis* can be detected directly from urine samples using the LAMP method ([@ref-18]). In this study, we also evaluated rapid swab processing without DNA extraction in order to begin to assess the POC potential of these assays. A total of 18 swabs taken from conjunctival and urogenital sites from koalas with presumptive chlamydiosis, of which four were stored in RNA Later and 14 were dry, were used for this experiment ([Table 7](#table-7){ref-type="table"}). Vigorously vortexed and heated swab suspension samples were directly used as a template in both *C. pecorum* LAMP reaction performed in fluorometer and qPCR assay. We also performed DNA extraction from the swabs to be used as a comparison to rapid swab processing. We did not detect *C. pecorum* DNA in any of the RNA Later suspensions either by LAMP nor qPCR assay ([Table 7](#table-7){ref-type="table"}), in contrast to detecting *C. pecorum* in 50% (2/4) of the DNA extracts from the swabs by both methods. Using the rapidly processed swab suspension as a template, *C. pecorum* was detected in 6/14 by LAMP, and only 2/14 by qPCR ([Table 7](#table-7){ref-type="table"}). The swab suspension LAMP results were 92.8% (13/14) congruent to the LAMP results and 85.7% congruent (12/14) to the qPCR results using the swab's paired DNA sample. In order to evaluate the potential presence of inhibitors in our samples, we "spiked" negative swab suspensions and its paired DNA samples with known amounts of *C. pecorum* (1 × 10^4^ copies/reaction). As observed in [Table 7](#table-7){ref-type="table"}, we detected *C. pecorum* by both LAMP and qPCR in "spiked" negative samples derived from dry swabs. No *C. pecorum* was detected in "spiked" RNA Later swab suspension, indicating the potential presence of inhibitors in these reactions. Our results suggest that the LAMP assays are capable of amplifying specific amplification products from crude DNA extracts.

Further work is additionally required to enhance the POC capabilities of these new chlamydial LAMP assays to meet the clinical need including (i) the evaluation of rapid swab processing methods using commercially available DNA release portable devices and/or sample preparation using microfluidic support; (ii) alternative amplification detection methods such as visible colorimetric or turbidimetric change and/or solid-phase 'dipstick' tests ([@ref-25]). With further development and the aforementioned focus on the preparation of these assays at the POC ([@ref-34]; [@ref-41]), it is anticipated that both LAMP tests described in this study may fill an important niche in the repertoire of ancillary diagnostic tools available to clinicians.
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###### *C. psittaci* and *C. pecorum* LAMP targets sequences alignment

A: A 263bp fragment of the Cps_0607 gene alignment; B: A 209bp fragment of the C.pec_HP gene alignment. SNPs in the alignments are highlighted.

###### 

Click here for additional data file.
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###### End-point detection of *C. pecorum* and *C. psittaci* LAMP performed on the thermal cycle

\(A\) *C. pecorum* LAMP sensitivity. In lanes 1: DNA marker VIII, 2: *C. pecorum* 10^5^ genome copy number dilution, 3: 10^4^ genome copy number dilution, 4: 10^3^ genome copy number dilution, 5: 10^2^ genome copy number dilution, 6: 10^1^ genome copy number dilution, 7: 10^0^ genome copy number dilution, 8: 10^−^1 genome copy number dilution, 9: 10^−^2 genome copy number dilution, 10: Negative (water as template), 11: Negative (mix only); (B) *C. pecorum* LAMP testing of clinical samples. In lanes 1: koala swab sample Chloe U, 2: Chloe R, 3: koala swab sample K61528, 4: K68199, 5: K67797, 6: K52866, 7: K60652, 8 and 11: DNA Marker VIII, 9: C. pecorum koala Marsbar strain, 10: Negative (water), 12: sheep eye swab S87, 13: Lamb1 eye swab, 14: cattle rectal swab 18R, 15: Cow brain sample, and 16: cattle rectal swab 20R; (C) *C. psittaci* LAMP sensitivity. In lanes 1: DNA marker VIII, 2: *C. psittaci* 10^5^ genome copy number dilution, 3: 10^4^ genome copy number dilution, 4: 10^3^ genome copy number dilution, 5: 10^2^ genome copy number dilution, 6: 10^1^ genome copy number dilution, 7: 10^0^ genome copy number dilution, 8: 10^−^1 genome copy number dilution, 9: 10^−^2 genome copy number dilution, 10: Negative (water as template), 11: Negative (mix only); (D) *C. psittaci* LAMP testing of clinical samples. In lanes 1: empty, 2: DNA Marker VIII, 3: Horse 14092/1, 4: Horse 10272/3, 5: Horse 13234/3, 6: Horse 11310/2, 7: Horse 12004/2, 8: Horse 12818/3, 9: Horse 11786/3, 10: Horse 11035/1, 11: Horse 13237/3, 12: Pigeon p12, 13: *C. psittaci* B2, 14: Negative (water as template); (E) *C. pecorum* LAMP specificity. In lanes 1: *C. psittaci*, 2: *C. pneumoniae*, 3: *C. abortus*, 4: *C. suis*, 5: *C. trachomatis*, 6: *Chlamydiales* positive sample (*Fritchea* spp.), 7 and 10: DNA Marker VIII, 8: *C. pecorum* koala Marsbar strain, 9: *C. pecorum* E58 cattle strain, 11 - 16: Gram Neg and Gram Pos bacteria, as follows: *Escherichia coli*, *Enterococcus feacalis*, *Fusobacterium* spp., *Prevotella bivia*, *Staphylococcus epidermidis*, *Streptococcus spp*., 17: empty, and 18-19: Negative (water and mix only).

###### 

Click here for additional data file.
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###### Specificity of the *C. psittaci* and *C. pecorum* LAMP assays

###### 

Click here for additional data file.
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###### *C. psittaci* LAMP testing of clinical samples

###### 

Click here for additional data file.
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###### *C. pecorum* LAMP testing of clinical samples

###### 

Click here for additional data file.
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